Please enter your password and login or 'click here to register'
Sign up for our email broadcasts
You are here: » Home
Promoting the interests of Dispensing Doctors and the excellence of doctor
dispensing for the benefit of patients
The DDA- Winner of IPRA Public Affairs Award 2009

2011 costs could exceed £6.6bn
Almost all EPS benefits yet to accrue
Pharmacy adequacy trumps serious difficulty
Rural Health Network announces second conference
Poulter says rurality is an important consideration
Out of stock expected until July
MSP raises pricing and monopoly concerns
Dispensary standards join the conference programme
DH admits system could be fairer
Patients told they don't need a right of appeal
Limited licensed stock still available
Isosorbide, sertraline, temazepam and trazodone
Restricted indications and new contraindications
Contamination fears prompt all-batch recall
Lancet findings “not new”

Side effects can be more important than benefits
MSPs challenged to act
Patient numbers down by more than 10%
Second briefing of 2013 calls for funded involvement
RPS publishes guide
Montelukast and Orlistat added, significant price changes
Domperidone price error corrected
AmdiPharm/Mercury lists 132 generics in RWM
Phoenix announces Daiichi Sankyo discount level
Current Sertraline minimum purchase price still higher than July's category M price
Generics houses start preparations
Remote health care is a fragile ecosystem
Hypertension
How should I endorse non Part VIIIB specials
Questions that need to be asked
Charging for prescriptions, and intervals
Resources answers and numbers
Out of stock expected until July
MSP raises pricing and monopoly concerns
Limited licensed stock still available
Restricted indications and new contraindications